• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

淋巴细胞趋化因子作为一种先天性黏膜佐剂。

Lymphotactin acts as an innate mucosal adjuvant.

作者信息

Lillard J W, Boyaka P N, Hedrick J A, Zlotnik A, McGhee J R

机构信息

Department of Microbiology and Immunobiology Vaccine Center, University of Alabama, Birmingham 35294, USA.

出版信息

J Immunol. 1999 Feb 15;162(4):1959-65.

PMID:9973465
Abstract

Lymphotactin (Lptn) is a C chemokine produced predominantly by NK and CD8-positive (CD8+) T cells including gammadelta TCR-positive (TCR+) intraepithelial lymphocytes. Lptn is chemotactic for NK and T cells and likely plays an important role in maintaining the integrity of the epithelium and in mucosal immune responses. In this study, we characterized the immune responses to OVA given intranasally with Lptn to mice. This regimen enhanced OVA-specific serum Ab responses and Ab titers in mucosal secretions. Lptn also enhanced OVA-specific Ab-forming cells in mucosal and systemic compartments. CD4-positive (CD4+) T cells isolated from mucosal compartments and spleens of mice intranasally immunized with OVA plus Lptn displayed higher OVA-specific proliferative responses and greater synthesis of IFN-gamma, IL-2, IL-4, IL-5, IL-6, and IL-10 than did CD4+ T cells from mice given OVA without Lptn. These studies indicate that Lptn has adjuvant properties and suggest that Lptn present in the mucosa has the potential to enhance mucosal and systemic Ab responses through help provided by Th1- and Th2-type cells to link the initial innate signals of the mucosa with the acquired immune system.

摘要

淋巴细胞趋化因子(Lptn)是一种C类趋化因子,主要由自然杀伤细胞(NK)和CD8阳性(CD8 +)T细胞产生,包括γδT细胞受体阳性(TCR +)上皮内淋巴细胞。Lptn对NK细胞和T细胞具有趋化作用,可能在维持上皮完整性和黏膜免疫反应中发挥重要作用。在本研究中,我们对用Lptn经鼻给予小鼠卵清蛋白(OVA)后的免疫反应进行了特征分析。该方案增强了OVA特异性血清抗体反应以及黏膜分泌物中的抗体滴度。Lptn还增强了黏膜和全身区室中OVA特异性抗体形成细胞。从经鼻用OVA加Lptn免疫的小鼠的黏膜区室和脾脏中分离出的CD4阳性(CD4 +)T细胞,与未用Lptn给予OVA的小鼠的CD4 + T细胞相比,表现出更高的OVA特异性增殖反应以及更高水平的γ干扰素、白细胞介素-2、白细胞介素-4、白细胞介素-5、白细胞介素-6和白细胞介素-10合成。这些研究表明Lptn具有佐剂特性,并提示黏膜中存在的Lptn有可能通过Th1型和Th2型细胞提供的辅助作用来增强黏膜和全身抗体反应,从而将黏膜的初始固有信号与获得性免疫系统联系起来。

相似文献

1
Lymphotactin acts as an innate mucosal adjuvant.淋巴细胞趋化因子作为一种先天性黏膜佐剂。
J Immunol. 1999 Feb 15;162(4):1959-65.
2
RANTES potentiates antigen-specific mucosal immune responses.调节活化正常T细胞表达和分泌的趋化因子增强抗原特异性黏膜免疫反应。
J Immunol. 2001 Jan 1;166(1):162-9. doi: 10.4049/jimmunol.166.1.162.
3
Lack of orally induced systemic unresponsiveness in IFN-gamma knockout mice.干扰素-γ基因敲除小鼠缺乏口服诱导的全身无反应性。
J Immunol. 1998 Feb 15;160(4):1687-93.
4
Synergistic enhancement of antitumor immunity with adoptively transferred tumor-specific CD4+ and CD8+ T cells and intratumoral lymphotactin transgene expression.通过过继转移肿瘤特异性CD4+和CD8+T细胞以及肿瘤内lymphotactin转基因表达协同增强抗肿瘤免疫力。
Cancer Res. 2002 Apr 1;62(7):2043-51.
5
Combined CD4+ Th1 effect and lymphotactin transgene expression enhance CD8+ Tc1 tumor localization and therapy.联合CD4 + Th1效应和淋巴细胞趋化因子转基因表达可增强CD8 + Tc1细胞在肿瘤部位的聚集及治疗效果。
Gene Ther. 2005 Jun;12(12):999-1010. doi: 10.1038/sj.gt.3302486.
6
Mucosally induced systemic T cell unresponsiveness to ovalbumin requires CD40 ligand-CD40 interactions.黏膜诱导的全身性T细胞对卵清蛋白无反应需要CD40配体与CD40的相互作用。
J Immunol. 1999 Feb 15;162(4):1904-9.
7
Mucosal immunity of nasopharynx: an experimental study in TCR-transgenic (OVA23-3) mice.鼻咽部黏膜免疫:在TCR转基因(OVA23-3)小鼠中的实验研究。
Rhinology. 2005 Sep;43(3):190-8.
8
IL-12 is an effective adjuvant for induction of mucosal immunity.白细胞介素-12是诱导黏膜免疫的有效佐剂。
J Immunol. 1999 Jan 1;162(1):122-8.
9
Non-toxic Stx derivatives from Escherichia coli possess adjuvant activity for mucosal immunity.来自大肠杆菌的无毒志贺毒素衍生物具有黏膜免疫佐剂活性。
Vaccine. 2004 Sep 9;22(27-28):3751-61. doi: 10.1016/j.vaccine.2004.03.034.
10
Interleukin 12 and innate molecules for enhanced mucosal immunity.白细胞介素12与增强黏膜免疫的固有分子。
Immunol Res. 1999;20(3):207-17. doi: 10.1007/BF02790404.

引用本文的文献

1
Implementing Personalized Medicine in COVID-19 in Andalusia: An Opportunity to Transform the Healthcare System.在安达卢西亚将个性化医疗应用于新冠肺炎:变革医疗体系的契机。
J Pers Med. 2021 May 26;11(6):475. doi: 10.3390/jpm11060475.
2
IL-7-Adjuvanted Vaginal Vaccine Elicits Strong Mucosal Immune Responses in Non-Human Primates.白细胞介素-7 佐剂阴道疫苗在非人灵长类动物中引发强烈的黏膜免疫应答。
Front Immunol. 2021 Feb 25;12:614115. doi: 10.3389/fimmu.2021.614115. eCollection 2021.
3
Innate endogenous adjuvants prime to desirable immune responses via mucosal routes.
先天性内源性佐剂通过黏膜途径引发理想的免疫反应。
Protein Cell. 2015 Mar;6(3):170-84. doi: 10.1007/s13238-014-0125-1. Epub 2014 Dec 13.
4
CCL5-independent helper T lymphocyte responses to immuno-dominant pneumococcal surface protein A epitopes.免疫显性肺炎链球菌表面蛋白 A 表位的 CCL5 非依赖性辅助性 T 淋巴细胞应答。
Vaccine. 2012 Feb 1;30(6):1181-90. doi: 10.1016/j.vaccine.2011.12.020. Epub 2011 Dec 14.
5
Modulation of immunogenicity and immunoprotection of mucosal vaccine against coxsackievirus B3 by optimizing the coadministration mode of lymphotactin adjuvant.通过优化趋化因子配体佐剂的联合给药方式来调节柯萨奇病毒 B3 黏膜疫苗的免疫原性和免疫保护作用。
DNA Cell Biol. 2012 Apr;31(4):479-88. doi: 10.1089/dna.2011.1367. Epub 2011 Oct 11.
6
Cytokines: the future of intranasal vaccine adjuvants.细胞因子:鼻内疫苗佐剂的未来
Clin Dev Immunol. 2011;2011:289597. doi: 10.1155/2011/289597. Epub 2011 Jul 31.
7
A parenteral DNA vaccine protects against pneumonic plague.一种注射用 DNA 疫苗可预防肺鼠疫。
Vaccine. 2010 Apr 19;28(18):3219-30. doi: 10.1016/j.vaccine.2010.02.022. Epub 2010 Mar 1.
8
Characterization of stability and nasal delivery systems for immunization with nanoemulsion-based vaccines.基于纳米乳剂疫苗免疫的稳定性和鼻腔递呈系统的特性研究。
J Aerosol Med Pulm Drug Deliv. 2010 Apr;23(2):77-89. doi: 10.1089/jamp.2009.0766.
9
Dendritic cell-targeting DNA-based mucosal adjuvants for the development of mucosal vaccines.用于黏膜疫苗开发的基于树突状细胞靶向DNA的黏膜佐剂
Expert Rev Vaccines. 2009 Sep;8(9):1183-93. doi: 10.1586/erv.09.80.
10
Exercise enhances vaccine-induced antigen-specific T cell responses.运动可增强疫苗诱导的抗原特异性T细胞反应。
Vaccine. 2008 Oct 3;26(42):5407-15. doi: 10.1016/j.vaccine.2008.07.081. Epub 2008 Aug 14.